|
[1] HENRY K. Paraneoplastic syndromes:Definitions,classification,pathophysiology and principles of treatment[J]. Semin Diagn Pathol,2019,36(4):204-210.
|
|
[2] BEHIN A,PSIMARAS D,HOANG-XUAN K,et al. Neuropathies in the context of malignancies[J]. Curr Opin Neurol,2008,21(5):534-539.
|
|
[3] SWEENEY L,HOWE T. Paraneoplastic syndromes[J]. Medicine,2016,44(1):69-72.
|
|
[4] MALIK AA,AZIZ F,BESHYAH SA,et al. Aetiologies of Hyperprolactinaemia:A retrospective analysis from a tertiary healthcare centre[J]. Sultan Qaboos Univ Med J,2019,19(2):e129-e134.
|
|
[5] SU XM,ZHANG R,ZHANG T,et al. Paraneoplastic syndrome as the initial symptom of intrahepatic cholangiocarcinoma:An analysis of 23 cases[J]. Chin J Misdiagn,2008,8(33):8280-8281.(in Chinese)苏晓妹，张汝，张涛，等．以副癌综合征为肝内胆管细胞癌首发症状23例分析[J]．中国误诊学杂志，2008,8(33):8280-8281.
|
|
[6] DIMITRIADIS GK,ANGELOUSI A,WEICKERT MO,et al. Paraneoplastic endocrine syndromes[J]. Endocr Relat Cancer,2017,24(6):r173-r190.
|
|
[7] KIM HL,BELLDERGRUN AS,FREITAS DG,et al. Paraneoplastic signs and symptoms of renal cell carcinoma:Implications for prognosis[J]. J Urol,2003,170(5):1742-1746.
|
|
[8] KRISTENSEN SB,HESS S,PETERSEN H,et al. Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes:A retrospective analysis of 137 patients[J]. Eur J Nucl Med Mol Imaging,2015,42(13):2056-2063.
|
|
[9] PELOSOF LC,GERBER DE. Paraneoplastic syndromes:An approach to diagnosis and treatment[J]. Mayo Clin Proc,2010,85(9):838-854.
|
|
[10] NEGISHI Y,SAKAI K,NOGUCHI Y,et al. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma[J]. J Obstet Gynaecol Res,2014,40(2):614-617.
|
DownLoad: